Cancel anytime
GRAIL, LLC (GRAL)GRAL
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: GRAL (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: 0% | Upturn Advisory Performance 5 | Avg. Invested days: 7 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: 0% | Avg. Invested days: 7 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 5 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 496.96M USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -58.29 |
Volume (30-day avg) 587033 | Beta - |
52 Weeks Range 12.33 - 23.36 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 496.96M USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -58.29 | Volume (30-day avg) 587033 | Beta - |
52 Weeks Range 12.33 - 23.36 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-13 | When - |
Estimate -6.43 | Actual -3.5027 |
Report Date 2024-11-13 | When - | Estimate -6.43 | Actual -3.5027 |
Profitability
Profit Margin - | Operating Margin (TTM) -640.47% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value -284404583 | Price to Sales(TTM) 4.22 |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding 33600800 | Shares Floating 21619290 |
Percent Insiders 13.75 | Percent Institutions 66.53 |
Trailing PE - | Forward PE - | Enterprise Value -284404583 | Price to Sales(TTM) 4.22 |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding 33600800 | Shares Floating 21619290 |
Percent Insiders 13.75 | Percent Institutions 66.53 |
Analyst Ratings
Rating 3 | Target Price - | Buy - |
Strong Buy - | Hold 1 | Sell - |
Strong Sell - |
Rating 3 | Target Price - | Buy - | Strong Buy - |
Hold 1 | Sell - | Strong Sell - |
About GRAIL, LLC
Exchange | NASDAQ | Headquaters | Menlo Park, CA, United States |
IPO Launch date | 2024-06-25 | CEO & Director | Mr. Robert P. Ragusa |
Sector | Healthcare | Website | https://grail.com |
Industry | Diagnostics & Research | Full time employees | 1360 |
Headquaters | Menlo Park, CA, United States | ||
CEO & Director | Mr. Robert P. Ragusa | ||
Website | https://grail.com | ||
Website | https://grail.com | ||
Full time employees | 1360 |
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.